Professor Juan Carlos Kaski - Professor of Cardiology (MD., DM (Hons), DSc, F.R.C.P., F.E.S.C., F.A.C.C.)

In 2001, Professor Kaski was awarded the degree of Doctor of Science (DSc) by the University of London. He is also Honoris Causae Professor, Universidad del Salvador, Buenos Aires, and Honorary Professor at the following universities: University of Sao Paulo, Brazil, University of Milan, Catholic University, Rome, University of Salamanca and University of Seville.

At present, he is Fellow of the Royal College of Physicians, the American College of Cardiology, the European Society of Cardiology and several other scientific societies. He was recently awarded the Gold Medal of the Spanish Society of Cardiology, the maximum distinction awarded by the Society, in recognition of his contribution to research and teaching.

Prof. Kaski was Chairman of the Microcirculation Working Group of the European Society of Cardiology. He is associate editor of several cardiology journals and a member of numerous editorial boards in major peer review scientific journal.

J. C. Kaski is the Professor of Cardiovascular Science St George's, University of London and Hon. Consultant Cardiologist at St George's Hospital Trust. He is also the Director of the Cardiovascular Biology Research Centre, and Deputy Head, Division of Cardiac and Vascular Sciences, St George's, University of London as well as the Director of Cardiology Undergraduate Teaching. Professor

Kaski's research focuses on Angina Pectoris, particularly mechanisms of rapid coronary artery disease progression, inflammation and atherogenesis, biomarkers of cardiovascular risk, and microvascular angina.

Professor Kaski lectures extensively in International fora and his achievements in teaching and research have earned him International reputation.  He has published over 350 papers in peer-review journals, 250 invited papers, 100 book chapters, three books and over 500 abstracts.

Some of Professor Kaski's most important peer-reviewed publications include:

Dumitriu, I.E., Trallero, A.E., Baboonian, C., and Kaski, J.C., 2009. CD4+CD28null T cells in coronary artery disease: when helpers become killers. Cardiovasc. Res. Jan 1;81(1):11-9.
Tziakas, D.N., Chalikias, G.K., Stakos, D., Tentes, I.K., Boudoulas, H., and Kaski, J.C., 2008. Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease. Coron. Artery Dis. 19, 583-590.
Zal, B., Kaski, J.C., Akiyu, J.P., Cole, D., Arno, G., Poloniecki, J., Madrigal, A., Dodi, A., and Baboonian, C., 2008. Differential pathways govern CD4+. J Immunol. 181, 5233-5241.
Arroyo-Espliguero, R., Avanzas, P., Quiles, J., and Kaski, J.C., 2008. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis.
Consuegra-Sanchez, L., Fredericks, S., and Kaski, J.C., 2008. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis Aug 12. [Epub ahead of print]
Dominguez-Rodriguez, A., Kaski, J.C., breu-Gonzalez, P., and Samimi-Fard, S., 2008. Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction. Atherosclerosis Aug 6. [Epub]
Tziakas, D.N., Chalikias, G.K., Tentes, I.K., Stakos, D.., Kortsaris, A.X., Kaski, J.C., and Boudoulas, H., 2008. Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome. Eur Heart J 29, 2713-2722.
Dominguez-Rodriguez, Abreu-Gonzalez, P., Garcia-Gonzalez, M.J., and Kaski, J.C., 2008. Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation. Thromb. Res. Jun 23. [Epub ahead of print]
Hermsmeyer, R.K., Thompson, T.L., Pohost, G.M., and Kaski, J.C., 2008. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity? Nature Clin Pract. Cardiovasc. Med. 5, 387-395.
Pries, A.R., Habazettl, H., Ambrosio, G., Hansen, P.R., Kaski, J.C., Weis, M., de, W.C., and Bugiardini, R., 2008. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc. Res. 80, 165-174.
Kaski, J.C., Consuegra-Sanchez, L., Fernandez-Berges, D.J., Cruz-Fernandez, J.M., Garcia-Moll, X., Marrugat, J., Mostaza, J., Toro-Cebada, R., Gonzalez-Juanatey, J.R., and Guzman-Martinez, G., 2008. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis Mar 10. [Epub]
Dominguez-Rodriguez, Abreu-Gonzalez, P., Garcia-Gonzalez, M.J., Samimi-Fard, S., Reiter, R.J., and Kaski, J.C., 2008. Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis 199, 73-78.
Dominguez-Rodriguez, Abreu-Gonzalez, P., Garcia-Gonzalez, M.J., and Kaski, J.C., 2008. High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and STEMI. Atherosclerosis 196, 365-371.
Roy , D. and Kaski, J.C., 2007. High-risk acute coronary syndrome patients and cardiac biomarkers in the emergency department: any role for new biomarkers of myocardial ischaemia? Eur Heart J 28, 2297-2298.
Roy , D. and Kaski, J.C., 2007. Ischemia-modified albumin: the importance of oxidative stress. J Am. Coll. Cardiol. 49, 2375-2376.
Tziakas, D.N., Kaski, J.C., Chalikias, G.K., Romero, C., Fredericks, S., Tentes, I.K., Kortsaris, A.X., Hatseras, D.I., and Holt, D.W., 2007. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? J Am. Coll. Cardiol. 49, 2081-2089.
Recio-Mayoral, A., Chaparro, M., Prado, B., Cozar, R., Mendez, I., Banerjee, D., Kaski, J.C., Cubero, J., and Cruz, J.M., 2007. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am. Coll. Cardiol. 49, 1283-1288.
Zal, B., Baboonian, C., and Kaski, J.C., 2007. Autoreactive CD4+. Arterioscler. Thromb. Vasc. Biol. 27, e18.
Motallebzadeh, R., Bland, J.M., Markus, H.S., Kaski, J.C., and Jahangiri, M., 2007. Neurocognitive function and cerebral emboli: randomized study of on-pump versus off-pump coronary artery bypass surgery. Ann Thorac. Surg. 83, 475-482.
Tziakas, D.N., Chalikias, G.K., Kaski, J.C., Kekes, A., Tentes, I.K., Kortsaris, A.X., and Hatseras, D.I., 2007. Inflammatory and anti-inflammatory variable clusters and risk prediction in ACS patients: a factor analysis approach. Atherosclerosis 193, 196-203.
Back to experts

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more


AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event